Literature DB >> 26426382

Carcinoma of the Uterine Cervix Involving the Genitourinary Tract: A Potential Diagnostic Dilemma.

Lauren E Schwartz1, Francesca Khani, Justin A Bishop, Russell Vang, Jonathan I Epstein.   

Abstract

Uterine cervical carcinoma secondarily involving the genitourinary tract is rarely documented histologically. These tumors present a unique diagnostic challenge as they can appear morphologically similar to urothelial carcinoma as well as primary squamous cell carcinoma and primary adenocarcinoma of the bladder. Genitourinary consult cases at the Johns Hopkins Hospital from 1984 to the present were searched for cases in which the differential diagnosis was primary bladder carcinoma versus secondary involvement by cervical carcinoma. We identified 10 cases that met these criteria and evaluated them by immunohistochemistry for p16 and GATA3 and in situ hybridization for human papillomavirus (HPV). Six cases were received with a gynecologic history. Four cases had been misdiagnosed as urothelial carcinoma, and 1 case was favored to be cystitis cystica et glandularis by the submitting institutions. Morphologically, the majority of cases showed basaloid nests of tumor cells infiltrating muscle bundles, with several having foci that mimicked urothelial carcinoma in situ. Six tumors were found to be diffusely positive with p16, 1 tumor was patchy, 1 was weak, and 2 were negative. GATA3 staining was negative in 6 cases, and 4 showed weak to strong positivity. Eight cases were positive for high-risk HPV (6 were positive for HPV 16, and 1 was positive for HPV 18). In the 2 cases that were negative for HPV by in situ hybridization, characteristic morphologic features of HPV-unrelated type of endocervical adenocarcinoma were present. On the basis of our findings we advocate a multifaceted approach, combining morphologic evaluation with ancillary studies including immunohistochemistry and in situ hybridization in the evaluation of genitourinary specimens for secondary involvement by cervical carcinoma. Furthermore, gynecologic clinical history is absolutely critical and most important to the evaluation and diagnosis of these specimens, as these ancillary studies are not completely sensitive or specific.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26426382     DOI: 10.1097/PAS.0000000000000524

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

1.  Non-invasive papillary urothelial carcinoma of the vagina: molecular analysis of a rare case identifies clonal relationship to non-invasive urothelial carcinoma of the bladder.

Authors:  Hind N Warzecha; Falko Fend; Julia Steinhilber; Harald Abele; Melanie Henes; Niklas Harland; Annette Staebler
Journal:  Virchows Arch       Date:  2017-06-07       Impact factor: 4.064

2.  Mesonephric adenocarcinoma of the uterine cervix with rare lung metastases: A case report and review of the literature.

Authors:  Li-Li Jiang; De-Ming Tong; Zi-Yi Feng; Kui-Ran Liu
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

Review 3.  Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.

Authors:  Sandra Lee; Marianne S Rose; Vikrant V Sahasrabuddhe; Rachel Zhao; Máire A Duggan
Journal:  Int J Gynecol Pathol       Date:  2017-07       Impact factor: 2.762

4.  A comprehensive evaluation of differentially expressed mRNAs and lncRNAs in cystitis glandularis with gene ontology, KEGG pathway, and ceRNA network analysis.

Authors:  Chao Li; Jiao Hu; Peihua Liu; Qiaqia Li; Jinbo Chen; Yu Cui; Xu Zhou; Bichen Xue; Xin Zhang; Xin Gao; Xiongbing Zu
Journal:  Transl Androl Urol       Date:  2020-04

5.  Detection of pagetoid urothelial intraepithelial neoplasia extending to the vagina by cervical screening cytology: a case report with renewed immunochemical summary.

Authors:  Yuki Koyanagi; Chiaki Kubo; Shigenori Nagata; Ayumi Ryu; Koji Hatano; Rieko Kano; Satoshi Tanada; Jun-Ichi Ashimura; Atsushi Idota; Shoji Kamiura; Tomoyuki Yamasaki; Shin-Ichi Nakatsuka
Journal:  Diagn Pathol       Date:  2019-02-02       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.